StockData
Black Diamond Therapeutics, Inc. logo

Black Diamond Therapeutics, Inc. (BDTX) income statement

BDTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$1.31−0.08 (-5.76%)

Close on Nov 20, 2026Market cap $75.26MP/E –Yield –

Black Diamond Therapeutics, Inc. financial ratios

See a number that looks wrong?